Summary: The head of the Food & Drug Administration, Scott Gottlieb, is leaving, so Heaton is officially nominating Stu Burguiere to be its new commissioner. He talks with Heaton about the false sense of security the FDA brings the public, and the ways it can be counterproductive for life-saving pharmaceuticals.
